Compositions and methods for reducing lactate levels
OwnerAbhinav P. Acharya, Niren Murthy +1inventors
InventorsAbhinav P. Acharya, Niren Murthy, Elliot C. Woods
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of reducing levels of lactate in a fluid or tissue in an individual. The present disclosure provides pharmaceutical compositions suitable for use in the methods.
Claims28
A pharmaceutical composition, comprising:
- a) a compound of formula I:
- wherein Z1 is CH, CR1 or N;
- Z2 is CH, CR2 or N;
- Z3 is CH, CR3 or N;
- R1, R2, R3, R4 and R5 are each independently selected from acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO2-alkyl, —SO2-substituted alkyl, —SO2-aryl, —SO2-heteroaryl and trihalomethyl;
- and
- R′ and R″ are each independently selected from hydrogen, an alkyl, an aryl, substituted alkyl and substituted aryl, and acyl;
- and
- b) a pharmaceutically acceptable excipient.
-3. (canceled)
A method of reducing the level of lactate in a fluid or tissue of an individual, the method comprising administering to the individual an effective amount of:
- a) a compound of formula I:
- wherein Z1 is CH, CR1 or N;
- Z2 is CH, CR2 or N;
- Z3 is CH, CR3 or N;
- R1, R2, R3, R4 and R5 are each independently selected from acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO2-alkyl, —SO2-substituted alkyl, —SO2-aryl, —SO2-heteroaryl and trihalomethyl;
- and
- R′ and R″ are each independently selected from hydrogen, an alkyl, an aryl, substituted alkyl and substituted aryl, and acyl;
- b) a compound of formula II:
- wherein R1, R2, R3, R4 and R5 are each independently selected from hydrogen, acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO2-alkyl, —SO2-substituted alkyl, —SO2-aryl, —SO2-heteroaryl and trihalomethyl;
- and
- R′ and R″ are each independently selected from hydrogen, an alkyl, an aryl, substituted alkyl and substituted aryl, and acyl;
- c) a compound of formula III:
- or
- d) a pharmaceutical composition comprising a compound of (a), (b), or (c),
- wherein said administering reduces the level of lactate in a fluid or tissue in the individual.
-10. (canceled)
-14. (canceled)
(canceled)
A method of treating a disease or disorder associated with elevated lactate in an individual, the method comprising:
- administering to the individual an effective amount of:
- a) a compound of formula I:
- wherein Z1 is CH, CR1 or N;
- Z2 is CH, CR2 or N;
- Z3 is CH, CR3 or N;
- R1, R2, R3, R4 and R5 are each independently selected from acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO2-alkyl, —SO2-substituted alkyl, —SO2-aryl, —SO2-heteroaryl and trihalomethyl;
- and
- R′ and R″ are each independently selected from hydrogen, an alkyl, an aryl, substituted alkyl and substituted aryl, and acyl;
- b) a compound of formula II:
- wherein R1, R2, R3, R4 and R5 are each independently selected from hydrogen, acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO2-alkyl, —SO2-substituted alkyl, —SO2-aryl, —SO2-heteroaryl and trihalomethyl;
- and
- R′ and R″ are each independently selected from hydrogen, an alkyl, an aryl, substituted alkyl and substituted aryl, and acyl;
- c) a compound of formula III:
- or
- d) a pharmaceutical composition comprising a compound of (a), (b), or (c),
- wherein the compound selectively binds to lactate and reduces the level of lactate in a tissue or fluid in the individual, thereby treating the disease or disorder associated with elevated lactate in the individual.
-28. (canceled)
-31. (canceled)
(canceled)
A method of treating lactic acidosis in an individual, the method comprising:
- administering to the individual an effective amount of:
- a) a compound of formula I:
- wherein Z1 is CH, CR1 or N;
- Z2 is CH, CR2 or N;
- Z3 is CH, CR3 or N;
- R1, R2, R3, R4 and R5 are each independently selected from acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO2-alkyl, —SO2-substituted alkyl, —SO2-aryl, —SO2-heteroaryl and trihalomethyl;
- and
- R′ and R″ are each independently selected from hydrogen, an alkyl, an aryl, substituted alkyl and substituted aryl, and acyl;
- b) a compound of formula II:
- wherein R1, R2, R3, R4 and R5 are each independently selected from hydrogen, acyloxy, hydroxy, thiol, acyl, alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, substituted alkyl, substituted alkoxy, substituted alkenyl, substituted alkynyl, substituted cycloalkyl, substituted cycloalkenyl, amino, substituted amino, aminoacyl, acylamino, alkaryl, aryl, aryloxy, azido, carboxyl, carboxylalkyl, cyano, halogen, nitro, heteroaryl, heteroaryloxy, heterocyclyl, heterocyclooxy, aminoacyloxy, oxyacylamino, thioalkoxy, substituted thioalkoxy, thioaryloxy, thioheteroaryloxy, —SO-alkyl, —SO-substituted alkyl, —SO-aryl, —SO-heteroaryl, —SO2-alkyl, —SO2-substituted alkyl, —SO2-aryl, —SO2-heteroaryl and trihalomethyl;
- and
- R′ and R″ are each independently selected from hydrogen, an alkyl, an aryl, substituted alkyl and substituted aryl, and acyl;
- c) a compound of formula III:
- or
- d) a pharmaceutical composition comprising a compound of (a), (b), or (c),
- wherein the boronic acid compound selectively binds to lactate and treats the lactic acidosis.
-36. (canceled)
Dependencies are inferred from the claim text.